Endovascular aortoiliac revascularization is a common treatment option for peripheral artery disease that carries non-negligible risks. Outcome prediction tools may support clinical decision-making but remain limited. We developed machine learning algorithms that predict 30-day…
Continue Reading
What You Should Know:
– Philips, a global leader in health technology, has announced a significant milestone in treating peripheral artery disease (PAD) by enrolling the first patient in the U.S. THOR IDE clinical trial.
–…
Continue Reading
Abbott earned a groundbreaking FDA approval on Monday for its dissolving stent designed to unclog arteries below the knee.
The device, called the Esprit BTK System, is meant to treat patients who have chronic limb-threatening…
Continue Reading
